People with kidney disease have been severely affected by COVID-19 with high rates of severe infection, critical illness and death.  The renal community welcomes the imminent arrival of effective COVID-19 vaccines.

Although some vaccines still need to be approved by MHRA, their development offers potential lifesaving protection to many clinically extremely vulnerable patients.

The joint renal societies (British Renal Society, British Transplantation Society, Renal Association) and charity partners at the National Kidney Federation and Kidney Care UK are committed to a co-ordinated approach to the vaccination of high-risk kidney patients against COVID-19.

Read their joint position statement and recommendations for people with kidney disease here: